Jane Street
GNOM icon

Jane Street’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Jane Street’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$655K Sell
11,522
-4,516
-28% -$215K ﹤0.01% 7430
2026
Q1 		$702K Buy
16,038
+3,425
+27% +$158K ﹤0.01% 7272
2025
Q4 		$573K Sell
12,613
-2,327
-16% -$103K ﹤0.01% 7379
2025
Q3 		$580K Buy
14,940
+6,934
+87% +$251K ﹤0.01% 7529
2025
Q2 		$270K Sell
8,006
-27,922
-78% -$884K ﹤0.01% 8043
2025
Q1 		$1.14M Buy
35,928
+2,577
+8% +$97.8K ﹤0.01% 5326
2024
Q4 		$1.3M Buy
33,351
+1,555
+5% +$65.3K ﹤0.01% 4913
2024
Q3 		$1.43M Sell
31,796
-4,138
-12% -$185K ﹤0.01% 5156
2024
Q2 		$1.5M Buy
35,934
+23,941
+200% +$1M ﹤0.01% 5008
2024
Q1 		$546K Sell
11,993
-136,211
-92% -$6.2M ﹤0.01% 6502
2023
Q4 		$6.85M Buy
148,204
+136,436
+1,159% +$5.56M ﹤0.01% 2419
2023
Q3 		$479K Buy
+11,768
New +$536K ﹤0.01% 6364
2023
Q1 		– Sell
-9,517
Closed -$482K – 9349
2022
Q4 		$482K Buy
+9,517
New +$491K ﹤0.01% 6200
2022
Q2 		– Sell
-9,581
Closed -$576K – 10084
2022
Q1 		$576K Buy
+9,581
New +$604K ﹤0.01% 7199
2021
Q1 		– Sell
-23,124
Closed -$2.19M – 9281
2020
Q4 		$2.19M Buy
23,124
+14,464
+167% +$1.21M ﹤0.01% 3329
2020
Q3 		$623K Buy
+8,660
New +$620K ﹤0.01% 4825
2020
Q1 		– Sell
-7,645
Closed -$477K – 5556
2019
Q4 		$477K Buy
+7,645
New +$438K ﹤0.01% 3743
2019
Q3 		– Sell
-6,304
Closed -$381K – 5320
2019
Q2 		$381K Buy
+6,304
New +$359K ﹤0.01% 3916

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

Jane Street's GNOM Position: Q2 2026 in Review

Jane Street reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 28% in Q2 2026, selling an estimated $215K and leaving 11,522 shares worth $655K. The position accounts for ﹤0.01% of the portfolio, ranked #7430.

Jane Street first reported a position in GNOM in Q2 2019 and has held it in 18 quarters since. The position peaked at $6.85M in Q4 2023. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Jane Street held 11,522 shares of Global X Genomics & Biotechnology ETF worth $655K as of Q2 2026.
  • Jane Street sold 4,516 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $215K.
  • Global X Genomics & Biotechnology ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7430 holding.
  • Jane Street first reported a position in Global X Genomics & Biotechnology ETF in Q2 2019 and has held it in 18 quarters since.
  • Jane Street's Global X Genomics & Biotechnology ETF position peaked at $6.85M in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.